Stay updated with breaking news from Lysatpharma gmbh. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Xlife Sciences AG / Key word(s): MiscellaneousPortfolio company Lysatpharma and joint venture Novaxomx start with research and product development in biosurgical treatment therapies 01.12.2022 / 07:01 CET/CESTLysatpharma, a portfolio company of Xlife Sciences (SIX: XLS), and Novaxomx, a joint-venture of Xlife Scienc. ....